FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin April 18, 2017 No Comments
FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia April 12, 2017 No Comments
European Commission approves Tafinlar with Mekinist for BRAF V600-positive NSCLC April 3, 2017 No Comments
FDA approves Zejula for the maintenance treatment of women with recurrent ovarian cancer March 28, 2017 No Comments
FDA approves Symproic for opioid-induced constipation in adults with chronic non-cancer pain March 24, 2017 No Comments
RSS